RAW264 MACROPHAGES STABLY TRANSFECTED WITH AN HIV-1 LTR REPORTER GENEPROVIDE A SENSITIVE BIOASSAY FOR ANALYSIS OF SIGNALING PATHWAYS IN MACROPHAGES STIMULATED WITH LIPOPOLYSACCHARIDE, TNF-ALPHA OR TAXOL
Mj. Sweet et Da. Hume, RAW264 MACROPHAGES STABLY TRANSFECTED WITH AN HIV-1 LTR REPORTER GENEPROVIDE A SENSITIVE BIOASSAY FOR ANALYSIS OF SIGNALING PATHWAYS IN MACROPHAGES STIMULATED WITH LIPOPOLYSACCHARIDE, TNF-ALPHA OR TAXOL, Journal of inflammation, 45(2), 1995, pp. 126-135
Bacterial lipopolysaccharide (LPS) modulates expression of a variety o
f genes in macrophages, and additionally activates viral promoters inc
luding the HIV-1 LTR. The HIV-1 LTR driving the luciferase reporter ge
ne was stably transfected into the murine macrophage cell line, RAW264
. In stably transfected cells, luciferase activity was LPS-dependent.
As little as 0.01 ng/ml LPS was sufficient to increase luciferase acti
vity over basal levels with maximal stimulation resulting in a 10- to
20-fold response. The cells also responded to human and murine tumour
necrosis factor (TNF alpha). Endogenous TNF alpha was not involved in
LPS responses, since pretreatment with alpha-TNF alpha antibody did no
t affect activation. Induction of HIV-1 LTR activity by LPS occurred i
ndependently of phorbol myristate acetate (PMA) sensitive protein kina
se C (PKC), since depletion of PKC by prolonged exposure to PMA blocke
d TNF alpha and PMA responses but was not able to abolish LPS action o
n these cells. Taxol (5-20 mu g/ml), a chemotherapeutic agent which mi
mics LPS action on macrophages, was also able to increase expression o
f the reporter gene driven by the HIV-1 LTR. However, lower doses of t
axol that were not sufficient to trans-activate the LTR or to induce T
NF alpha expression were cytotoxic to RAW264 cells suggesting that the
cytotoxic and LPS-like activities of taxol were not linked. This cell
line provides a convenient method for detecting LPS-like activity and
is a useful tool for examining LPS and TNF alpha signal ling pathways
. (C) 1995 Wiley-Liss, Inc.